A significant discovery in cancer study is arising with the use of mini-antibodies to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in various forms of malignancies, https://kingbookmark.com/story22008095/vhh-fragments-revive-the-p53-protein-new-promising-hope-for-tumor-management